InvestorsHub Logo
Followers 149
Posts 9262
Boards Moderated 5
Alias Born 03/29/2017

Re: None

Friday, 03/16/2018 1:41:21 PM

Friday, March 16, 2018 1:41:21 PM

Post# of 111069
Love this new Sub they created. Going after something that is an side effect of treatment for brain cancer is awesome. Lot of growth in this one. Especially since we are @ near 52 week low.

52-Wk Range
0.0021 - 0.70


Creative Medical Technology Holdings, Inc. announced the formation of CerebroStem LLC, a majority owned subsidiary focused on developing stem cell therapies for brain injuries and neurodegenerative diseases. The company's initial focus will be treating radiation induced brain damage, a major cause of cognitive dysfunction in patients with brain cancer who have received radiation therapy. In addition to treating radiation induced brain damage, CerebroStem LLC plans to pursue other areas of brain degeneration including stroke, multiple sclerosis, and Parkinson's Disease.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News